PhuturdexDrug Pipeline Intelligence

Phuturdex › Drugs › Denosumab

Drugs in development · updated 30 October 2026

Denosumab: clinical trials and development status

Other names and codes: Prolia, Degevma, Oziltus, Boncresa, Bilprevda

NLM verified identityApproved in the US (FDA)Authorised in the EU (EMA) since 26 May 2010

As of 30 October 2026 Denosumab is in 19 active clinical trials (recruiting or ongoing, phases I–III) for 18 diseases. The most advanced phase is III.

19Active trials
IIIMost advanced phase
18Diseases studied

Summary updated every week · data as of 30 October 2026. In Phuturdex you can follow Denosumab and get an email at every change or safety alert.

Sign in free →

Diseases studied

For each disease: the drug’s most advanced phase and active trials, with the reference trial on ClinicalTrials.gov.

DiseaseMost advanced phaseActive trialsReference trial
Breast neoplasmIII4NCT04711109
Bone diseaseIII2NCT06314698
Breast diseaseIII1NCT04711109
DiabetesIII1NCT04547348
Giant-cell tumor of boneIII1NCT05813665
Multiple myelomaIII1NCT06314698
NeoplasmIII1NCT04711109
OsteoporosisII2NCT04608630
Critical illnessII1NCT04608630
Fibrous dysplasia of boneII1NCT03571191
Hepatocellular carcinomaII1NCT07537972
Lung neoplasmII1NCT06749886
Male infertilityII1NCT05212337
PainII1NCT03571191
Postmenopausal osteoporosisII1NCT07806331
SclerosteosisII1NCT07806331
Type-1 diabetesI–II1NCT06524960
OsteoarthritisI1NCT07085520

Everything on Denosumab

In Phuturdex you get every trial with sponsors, countries and dates, development events, FDA and EMA approvals, patents and exclusivities, orphan designations and safety alerts, with PDF and Excel export. Free until 31 March 2027.

Open in Phuturdex →

Source: Phuturdex analysis of ClinicalTrials.gov (U.S. National Library of Medicine), FDA and EMA data, updated 30 October 2026. Active trials = recruiting or ongoing, phases I–III. Diseases are those named by each trial (NLM MeSH terms). The estimated launch, when shown, is a Phuturdex calculation described on the Method page, not official data.

ItalianoFrançaisDeutsch